Saudi Arabia SFDA registration ME0000002814SFDAA00252
BD Oncomark™ CD103/CD22/CD20
Saudi Arabia·Chemicals·Becton, Dickinson and Company, BD Biosciences·General IVD(Others)ActiveProduct information
Anti CD103/CD22/CD20 for flow cytometer
Product use
BD Oncomark™ CD103 FITC/CD22 PE/
CD20 PerCP-Cy™5.5* is intended for in
vitro flow cytometric
immunophenotyping of normal and
abnormal subsets of B lymphocytes. The
reagents detect expression of the CD103,
CD22, and CD20 antigens. These
antigens are highly expressed in the
abnormal cells of hairy-cell leukemia. A
subset of normal B cells expressing
CD103 has been identified in peripheral
blood.1 CD103/CD22/CD20 assays are
used in the diagnosis of hematologic
disorders.
Device classification
- Risk Class
- General IVD(Others)
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000002814SFDAA00252
- Authorization ID
- GHTF-2017-0924
- Status
- Active
- Expire Date
- June 21, 2023
Manufacturer
- Manufacturer Name
- Becton, Dickinson and Company, BD Biosciences
Model information
- Model ID(s)
- 333174
Product accessories
[]
About this record
Access comprehensive regulatory information for BD Oncomark™ CD103/CD22/CD20 in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000002814SFDAA00252 and manufactured by Becton, Dickinson and Company, BD Biosciences.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataGeneral IVD(Others)